Key result
Cr51-labeled platelets mildly damaged by immunologic means were slowly destroyed in the spleen, whereas severely damaged cells were rapidly removed from the circulation by the liver.
Observational (n=11)
No
The study demonstrates that the degree of platelet sensitization by isoantibodies determines the primary site of sequestration, with mild sensitization leading to splenic trapping and severe sensitization causing rapid hepatic clearance.
Answers are grounded in this paper and cite their sources.
Severity of immunologic platelet sensitization may determine sequestration site; leaves open whether this informs management of antibody-mediated thrombocytopenia.
The mechanisms of platelet destruction and their sites of sequestration in disease states are poorly understood.Although recent studies have emphasized the importance of platelet isoanti- bodies in certain clinical situations (1-3), little is known of the effects of antibodies on platelets in vivo.In conditions such as idiopathic thrombocytopenic purpura, there is debate as to whether immune mechanisms are involved, and sites of platelet sequestration are unknown.The availability of a method for labeling plate- lets with Cr5' that allows most of the transfused platelets to remain viable and reduces the initial deposition of nonviable platelets in the liver and spleen (4) permits study of some of these aspects of platelet pathophysiology.We investigated the survival and sites of sequestration of platelets exposed to isoantibodies in vivo.Included in this paper are observations of pyrogenic reactions after immune platelet destruction.Studies in patients with idiopathic thrombocytopenic purpura and other platelet disorders are also described. Methods Preparation and transfusion of Cr51-!abeled "citrateplatelets" and determination of the percentage of plate- let survival were as described in the preceding report (4).In "extracting" Cr51-labeled platelets from blood samples taken from thrombocytopenic persons, non- radioactive platelets were added to the platelet-rich plasma to facilitate recovery of platelet Cr51.For isologous transfusions, only platelets from donors compatible with the recipients' ABO and Rh blood types were used.Methods of scintillation scanning over organs to evalu- ate sites of platelet sequestration have been described
No takes yet. Share an insight, caveat, or question.
Aster et al. (1964) conducted an observational in Idiopathic thrombocytopenic purpura and isoimmunity (n=11). Cr51-labeled platelet transfusion and isoantibody injection was evaluated on Platelet survival (half-disappearance time) and site of sequestration. Cr51-labeled platelets mildly damaged by immunologic means were slowly destroyed in the spleen, whereas severely damaged cells were rapidly removed from the circulation by the liver.
Synapse has enriched 10 related papers. Consider them for comparative context: